The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

WEIGHT loss jabs could banish blues as well as bellies, a study claims. People taking the injections showed “significantly ...

The study published in the journal JAMA Ophthalmology focused on semaglutide, the GLP-1 agonist in Novo Nordisk’s diabetes therapy Ozempic ... of suicide, but no strong evidence for a link ...